Back
 IJCM  Vol.7 No.7 , July 2016
Clinical Assessment of the Use of Propinox Hydrochloride and Scopolamine Hydrochloride in the Treatment of Abdominal Colic: A Retrospective, Comparative Study
Abstract: Objectives: The purpose of this study was to evaluate and compare the use of propinox hydrochloride and scopolamine hydrochloride in patients presenting abdominal colic (abdominal pain), in terms of treatment efficacy and tolerability. Material & Methods: This was an analytical, retrospective, comparative study based on hospital records of outpatients treated at Serviço de Clínica Médica do Hospital das Clínicas Costantino Otaviano (HCTCO) and at Santa Casa de Misericórdia do Rio de Janeiro, from 1988-1998. Subjects were divided into two groups: patients from Group 1 were treated with propinox hydrochloride, while patients from Group 2 were treated with scopolamine hydrochloride. Statistical analysis was performed using GraphPad Prism version 5.0. For comparison of categorical variables, we used the chi-squared or Fisher’s test, while continuous variables were analyzed using ANOVA or the Student’s T test. Results: A total of 1042 subjects were included, of which 525 were allocated to Group 1 and 517 to Group 2. Mean treatment duration was 9.166 days (±4.208) in Group 1 and 8.795 days (±5.052) in Group 2, with no statistically significant difference in treatment duration between the two groups (p = 0.198). All subjects in Group 1 were treated with propinox 10 mg (2 coated tablets, three times per day) while all subjects in Group 2 were treated with scopolamine hydrochloride 10 mg (2 coated tablets, three times per day). There were no statistically significant between-group differences in weight, BMI, heart rate, and respiratory rate at pre- and post-treatment; with the exception of higher post-treatment systolic blood pressure in Group 1, blood pressure measures also remained homogenous. Adverse events were reported among both treatment groups with no significant between-group difference in incidence (p = 0566). At pretreatment, pain intensity was more severe in Group 1 (p = 0.0257), while at post-treatment, there was no statistically significant difference between the two treatment groups (p = 0.895). There was a statistically significant improvement in pain intensity within both treatment groups (χ2 = 631.4; df = 3; p < 0.0001 for Group 1 and χ2 = 554.3; df = 3; p < 0.0001 for Group 2). Conclusion: The results obtained in this study indicate a therapeutic equivalence between propinox hydrochloride and scopolamine hydrochloride. Both treatments demonstrated good efficacy and tolerability in the treatment of abdominal colic pain, in the population evaluated.
Cite this paper: Rzetelna, H. , Porto Alegre Rosa, C. , Kirzner, M. , de Medeiros, L. , Melo, C. , Ribeiro, M. , Oliveira, L. , Galvão Alves, J. , Geller, M. , (2016) Clinical Assessment of the Use of Propinox Hydrochloride and Scopolamine Hydrochloride in the Treatment of Abdominal Colic: A Retrospective, Comparative Study. International Journal of Clinical Medicine, 7, 474-480. doi: 10.4236/ijcm.2016.77052.
References

[1]   Sweetman, S (Ed.) (2007) Martindale: The Complete Drug Reference. 35th Edition, Pharmaceutical Press, London.

[2]   Baistrocchi, R.L., Orti, E., de los Santos, A.R., et al. (1999) Antispasmodic Action of Propinox on the Isolated Human Gallbladder: Possible Mechanism of Action. Acta Physiologica, Pharmacologica et Therapeutica Latinoamericana, 49, 161-169.

[3]   Hardman, J.G., Limbird, L.E. and Gilman, A.G. (2001) Goodman & Gilman’s The Pharmacological Basis of Therapeutics. 10th Edition, McGraw-Hill, New York.

[4]   Sasaki, D., Kido, A. and Yoshida, Y. (1984) Effect of Antispasmodic Drugs on Coloinc Motility. Part I: Laboratory Study of the Dog. International Journal of Clinical Pharmacology, Therapy, and Toxicology, 22, 333-337.

[5]   Baistrocchi, R.L., Orti, E., de los Santos, A.R., et al. (1999) Comparison of the Isolated Human and Guinea-Pig Gallbaldder Strip Models in the Assessment of Antispasmodic Drugs. Methods and Findings in Experimental and Clinical Pharmacology, 21, 659.
http://dx.doi.org/10.1358/mf.1999.21.10.795736

[6]   Sasaki, D., Kido, A. and Yoshida, Y. (1984) Effect of Antispasmodic Drugs on Coloinc Motility. Part II: Clinical Study in Man. International Journal of Clinical Pharmacology, Therapy, and Toxicology, 22, 338-341.

[7]   Forbes, O.C. and Marshall, P.B. (1951) Pharmacology of Benzilic Acid Derivaties. British Journal of Pharmacology, 6, 634-642.

[8]   Weaver, L.C., Abreu, B.E., Alexander, W.M., et al. (1959) Pharmacologic Properties of Certain Beta-diethylaminothyl-4-alkoxybenzilates. Archives Internationales de Pharmacodynamie, 121, 415.

[9]   Baistrocchi, R., Orti, E., de los Santos, A.R., et al. (1997) Antispasmodic Action of Propinoxhydrochloride (P) on the Gallbladder. Possible Mechanism of Action. Medicina, 57, 61.

[10]   de los Santos, A.R., Martí, M.L., di Girolamo, G., et al. (1999) Propinox in Biliary Colic: A Multicenter, Randomized, Prospective and Parallel Double-Blind Study of Three Doses of Propinox versus Placebo in Acute Biliary Colic Pain. International Journal of Tissue Reactions, 21, 13-18.

[11]   Di Giroamo, G., de los Santos, A.R., Marti, M.L., et al. (2000) Propinox in Intestinal Colic: Multicenter Randomized Prospective Double-Blind Study of Three Doses of Propinox vs. Placebo in Acute Intestinal Colic Pain. International Journal of Clinical Pharmacology Research, 20, 31-40.

[12]   Mezzotero, O., Arriaga, A.A.S. and Tobar, J.C. (1995) [Clinical Trial with Propinox (10 mg) Pearls in Abdominal Colic: A Multicenter Study]. Prensa Medica Argentina, 82, 428.

[13]   Olmos, J.á., Seehaus, A., Peralta, D., et al. (2003) [Efficacy of Propinox in Reverting Colonic Spasm during Colon Enema in Patients with Irritable Bowel]. Medicina Interna, 3, 127.

[14]   Pulpiero, A., Marí, M.L., de los Santos, A.R., et al. (2000) [Propinox in Irritable Bowel Syndrome]. Prensa Medica Argentina, 87, 299.

[15]   Evangelista, S. (2004) Quaternary Ammonium Derivatives as Spasmolytics for Irritable Bowel Syndrome. Current Pharmaceutical Design, 10, 3561.
http://dx.doi.org/10.2174/1381612043382972

[16]   Tytgat, G.N. (2007) Hysocine Butylbromide: A Review of Its Use in the Treatment of Abdominal Cramping and Pain. Drugs, 67, 1343-1357.
http://dx.doi.org/10.2165/00003495-200767090-00007

[17]   Schafer, E. and Ewe, K. (1990) The Treatment of Irritable Colon: Efficacy and Tolerance of Buscopan Plus, Buscopan, Paracetamol and Placebo in Ambulatory Patients with Irritable Colon. Fortschritte der Medizin, 108, 488-492.

[18]   Sanchez Martinez, J. and Goiz Durán, I. (1988) Clinical Assessment of the Tolerability and Effect of IK-19 in Tablet Form on Pain of Spastic Origin. Investigacion Medica Internacional, 15, 63.

[19]   Nigam, P., Kapoor, K.K., Rastog, C.K., et al. (1984) Different Therapeutic Regimens in Irritable Bowel Syndrome. The Journal of the Association of Physicians of India, 32, 1041-1044.

[20]   Miyoshi, A. (1976) A Multi-Centre, Double-Blind Evaluation against Placebo of the Therapeutic Effect of Hyoscine-N-butylbromide in Patients with Abdominal Pain. Pharmatherapeutica, 1, 46.

[21]   De Gregorio, M., Damiani, S. and Gatta, G. (1969) Antalgic Properties of Proxazole: Double Blind Study in Visceral Algoplastic Conditions. Panminerva Medica, 11, 436.

[22]   Ritchie, J.A. and Truelove, S.C. (1979) Treatment of Irritable Bowel Syndrome with Lorazepam, Hyoscine Butylbromide, and Ispaghula Husk. BMJ, 1, 376.
http://dx.doi.org/10.1136/bmj.1.6160.376

[23]   Mueller-Lissner, S., Tytgat, G.N., Paulo, L.G., et al. (2006) Placebo- and Paracetamol-Controlled Study on the Efficacy and Tolerability of Hysoscine Butylbromide in the Treatment of Patients with Recurrent Crampy Abdominal Pain. Alimentary Pharmacology & Therapeutics, 23, 1741.
http://dx.doi.org/10.1111/j.1365-2036.2006.02818.x

[24]   Navarro Martinez, P. (1972) Statistical Double-Blind Study on the Therapeutic Preference of Chronic Gastropathic Subjects in Acute Crises. Revue Médicale Suisse, 4, 77.

[25]   Metzger, K.H. (1979) The Effect of Anticholinergic Agents on Caudal Intestinal Sections: Experimental Investigations into Motility. Ärztliche Praxis, 21, 923.

[26]   Sieg, H. (1974) Double Blind Test Using Hyoscine-N-butyl Bromide (Buscopan) to Reduce Pain in Ulcus Ventriculi. Zeit-schrift für Gastroenterologie, 12, 235.

 
 
Top